A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Natera, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 40,558 shares of NTRA stock, worth $6.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
40,558
Previous 49,272 17.69%
Holding current value
$6.83 Million
Previous $5.34 Million 3.39%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $851,793 - $1.13 Million
-8,714 Reduced 17.69%
40,558 $5.15 Million
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $4.2 Million - $5.55 Million
49,272 New
49,272 $5.34 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.